GlassScriptPhysician profile
Ronald S Hulse
NPI 1245329127
$7,872.10
in general payments reported to CMS, 2019-2025
36 companies · $1,704 in 2025
The $1,704 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $397 · 2021: $719 · 2022: $1,402 · 2023: $1,592 · 2024: $1,257 · 2025: $1,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,512 · Entertainment: $33.63 · Education: $6.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,512.47 |
| Entertainment | $33.63 |
| Education | $6.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $766.38 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $757.02 | 2019-2025 | |
| Medtronic, INC. | $698.81 | 2021-2024 | Reveal Linq |
| Merck Sharp & Dohme LLC | $618.48 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $556.79 | 2019-2025 | Farxiga |
| Abbott Laboratories | $554.43 | 2019-2023 | Aveir |
| Pfizer INC. | $463.57 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $461.76 | 2019-2025 | Lifevest |
| Amgen INC. | $343.28 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $296.22 | 2019-2025 | Eliquis, Camzyos |
| Cvrx, INC. | $294.26 | 2021-2025 | Barostim Neo System |
| Heartflow, INC. | $286.44 | 2025 | |
| Boston Scientific Corporation | $212.86 | 2019-2025 | Farapulse, Watchman Flx, Watchman Access System |
| Atricure, INC. | $198.06 | 2022 | |
| Janssen Pharmaceuticals, INC | $185.95 | 2019-2022 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hulse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.